223 related articles for article (PubMed ID: 11447162)
1. Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci.
Malley R; Lipsitch M; Stack A; Saladino R; Fleisher G; Pelton S; Thompson C; Briles D; Anderson P
Infect Immun; 2001 Aug; 69(8):4870-3. PubMed ID: 11447162
[TBL] [Abstract][Full Text] [Related]
2. Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccine.
Lu YJ; Yadav P; Clements JD; Forte S; Srivastava A; Thompson CM; Seid R; Look J; Alderson M; Tate A; Maisonneuve JF; Robertson G; Anderson PW; Malley R
Clin Vaccine Immunol; 2010 Jun; 17(6):1005-12. PubMed ID: 20427625
[TBL] [Abstract][Full Text] [Related]
3. Serotype-independent protection against pneumococcal infections elicited by intranasal immunization with ethanol-killed pneumococcal strain, SPY1.
Xu X; Meng J; Wang Y; Zheng J; Wu K; Zhang X; Yin Y; Zhang Q
J Microbiol; 2014 Apr; 52(4):315-23. PubMed ID: 24682994
[TBL] [Abstract][Full Text] [Related]
4. Intranasal vaccination with γ-irradiated Streptococcus pneumoniae whole-cell vaccine provides serotype-independent protection mediated by B-cells and innate IL-17 responses.
Babb R; Chen A; Hirst TR; Kara EE; McColl SR; Ogunniyi AD; Paton JC; Alsharifi M
Clin Sci (Lond); 2016 May; 130(9):697-710. PubMed ID: 26831937
[TBL] [Abstract][Full Text] [Related]
5. Multiserotype protection of mice against pneumococcal colonization of the nasopharynx and middle ear by killed nonencapsulated cells given intranasally with a nontoxic adjuvant.
Malley R; Morse SC; Leite LC; Areas AP; Ho PL; Kubrusly FS; Almeida IC; Anderson P
Infect Immun; 2004 Jul; 72(7):4290-2. PubMed ID: 15213177
[TBL] [Abstract][Full Text] [Related]
6. Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide.
Lu YJ; Forte S; Thompson CM; Anderson PW; Malley R
Infect Immun; 2009 May; 77(5):2076-83. PubMed ID: 19255193
[TBL] [Abstract][Full Text] [Related]
7. Mucosal and systemic immunization with a novel attenuated pneumococcal vaccine candidate confer serotype independent protection against Streptococcus pneumoniae in mice.
Wu K; Yao R; Wang H; Pang D; Liu Y; Xu H; Zhang S; Zhang X; Yin Y
Vaccine; 2014 Jul; 32(33):4179-88. PubMed ID: 24945468
[TBL] [Abstract][Full Text] [Related]
8. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
[TBL] [Abstract][Full Text] [Related]
9. Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae.
Tostes RO; Rodrigues TC; da Silva JB; Schanoski AS; Oliveira ML; Miyaji EN
PLoS One; 2017; 12(1):e0170157. PubMed ID: 28103277
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immunization with polyamine transport protein D (PotD) protects mice against nasopharyngeal colonization with Streptococcus pneumoniae.
Shah P; Briles DE; King J; Hale Y; Swiatlo E
Exp Biol Med (Maywood); 2009 Apr; 234(4):403-9. PubMed ID: 19176871
[TBL] [Abstract][Full Text] [Related]
11. Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice.
Pimenta FC; Miyaji EN; Arêas AP; Oliveira ML; de Andrade AL; Ho PL; Hollingshead SK; Leite LC
Infect Immun; 2006 Aug; 74(8):4939-44. PubMed ID: 16861686
[TBL] [Abstract][Full Text] [Related]
12. Immunization with DnaJ (hsp40) could elicit protection against nasopharyngeal colonization and invasive infection caused by different strains of Streptococcus pneumoniae.
Cui Y; Zhang X; Gong Y; Niu S; Yin N; Yao R; Xu W; Li D; Wang H; He Y; Cao J; Yin Y
Vaccine; 2011 Feb; 29(9):1736-44. PubMed ID: 21238570
[TBL] [Abstract][Full Text] [Related]
13. Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide.
Malley R; Srivastava A; Lipsitch M; Thompson CM; Watkins C; Tzianabos A; Anderson PW
Infect Immun; 2006 Apr; 74(4):2187-95. PubMed ID: 16552049
[TBL] [Abstract][Full Text] [Related]
14. Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins.
Basset A; Thompson CM; Hollingshead SK; Briles DE; Ades EW; Lipsitch M; Malley R
Infect Immun; 2007 Nov; 75(11):5460-4. PubMed ID: 17698570
[TBL] [Abstract][Full Text] [Related]
15. IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine.
Campos IB; Herd M; Moffitt KL; Lu YJ; Darrieux M; Malley R; Leite LC; Gonçalves VM
Vaccine; 2017 Mar; 35(9):1306-1315. PubMed ID: 28161422
[TBL] [Abstract][Full Text] [Related]
16. Host immunity in the protective response to nasal immunization with a pneumococcal antigen associated to live and heat-killed Lactobacillus casei.
Vintiñi EO; Medina MS
BMC Immunol; 2011 Aug; 12():46. PubMed ID: 21834957
[TBL] [Abstract][Full Text] [Related]
17. Enhanced protective responses to a serotype-independent pneumococcal vaccine when combined with an inactivated influenza vaccine.
Babb R; Chen A; Ogunniyi AD; Hirst TR; Kara EE; McColl SR; Alsharifi M; Paton JC
Clin Sci (Lond); 2017 Jan; 131(2):169-180. PubMed ID: 27885052
[TBL] [Abstract][Full Text] [Related]
18. Protection against systemic fatal pneumococcal infection by maternal intranasal immunization with pneumococcal surface protein A (PspA).
Katsurahara T; Hotomi M; Yamauchi K; Billal DS; Yamanaka N
J Infect Chemother; 2008 Dec; 14(6):393-8. PubMed ID: 19089550
[TBL] [Abstract][Full Text] [Related]
19. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
20. Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection.
Hvalbye BK; Aaberge IS; Løvik M; Haneberg B
Infect Immun; 1999 Sep; 67(9):4320-5. PubMed ID: 10456869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
